What is Rejuve.AI (RJV)?
Rejuve.AI is a new way of conducting beneficial research to improve human healthspan & lifespan by aggregating the data of millions of people around the world and applying innovative AI tools and methods.
This begins with the Longevity mobile app (for both iOS and Android) which allows anyone with a smartphone to begin logging their personal health data to receive valuable AI-driven health insights. User data is protected in secure encrypted service, with the near-term goal of being fully HIPAA compliant.
Users can then elect to participate in our research program, by creating their unique Data NFT (dNFT) which acts as their Rejuve Network membership identity token, also keeping track of any permissions granted to access their data. After receiving this NFT (which Rejuve mints for free to the user), they can then begin to earn RJV tokens in exchange for submitting their data to the Rejuve Data Commons (our database) which can be redeemed in exchange for discounted access to health-enhancing products & services (including those which will allow them to contribute more data and earn more tokens). Some of these products include but are not limited to: wearable health tracker devices, whole genome sequencing kits, epigenetic/biological age tests, science-backed supplements, consultations with physicians, and more!
As an additional feature, users can elect via their dNFT Dashboard to allow outside entities (Rejuve Network partners) to access their health data to conduct further research/achieve other goals. In the event that research (whether by Rejuve Network, our therapeutics subdivision Rejuve Biotech, or other partners) leads to a viable product (ex. a new drug), all members whose data was use to make this product possible will earn Product NFT (pNFT) shards, which represent ownership of that product. Holding pNFT shards will periodically distribute RJV according to proceeds generated from that product.
In addition to submitting health data, AI scientists and developers can contribute models to our system in exchange for pNFTs, via our Generative Cooperative Network (GCN), a system designed to aggregate crowdsourced models for longevity to create a multi-resolutional simulation of the human body. These simulations can be used to test new therapies ahead of clinical trials and gain new insight on the aging process.
What makes Rejuve.AI (RJV) unique?
Rejuve.AI is a unique effort spanning Artificial Intelligence, Blockchain/Web3 economy, and Longevity Science. While there are other companies focused on longevity research and data aggregation in various ways, there are none doing exactly what Rejuve is doing: Providing a value-added decentralized research network that allows widespread citizen science, takes the guesswork out of finding and accessing high-quality products and services to benefit overall health, creates an ever-growing proto-AGI system focused on curing aging, all while fairly compensating contributors of the valuable data that makes this all possible.
Our team boasts of top researchers in the field including Dr. Ben Goertzel, esteemed AI/AGI researcher and Dr. Deborah Duong, Computational and social scientist, both having 30+ years of experience, including developing solutions used by the U.S. government and military.
Data is being siphoned everyday by various applications we all use regularly, Rejuve is the only project actually rewarding you for these contributions, not only in the immediate term, but for the entire duration of its usefulness into perpetuity.
Another unique feature is our partnership/subdivision Rejuve Biotech, focusing on AI-driven longevity therapeutics discovery. Rejuve Biotech has an exclusive license to the longest lived drosophila melanogaster fruit flies in the world (dubbed ‘Methuselah flies’), with leading biologist Kennedy Schaal, selectively breeding these files for long live for over a decade. By studying the genomes of these flies, this knowledge can be used in AI knowledge transfer to map analogues to the human genome to lead to extended lifespan, disease mitigation, synthetic animal models, and more.
Therapies generated via Rejuve Biotech and Rejuve Network member data will be available to the Network members first, and at a deeply discounted rate.
What is Rejuve.AI (RJV) roadmap?
Going along with this general roadmap will be regular UX/UI enhancements to the app (including increased gamification and opportunities to earn rewards, and more ways to spend RJV), more partners added to the Rewards Store with greater discounts and product offerings, and further development and scientific validation of our AI algorithms.
Rejuve.AI (RJV) revenue streams
Revenue streams include:
1) Premium subscriptions to the app (monthly or yearly subscription to receive enhanced functionality and benefits in the Longevity app)
2) Affiliate commissions on partner vendor product sales (Sales generated from users purchasing products in the app or via referral links clicked on in our blogs, social media, and other communication channels)
3) Data licensing fees (Cut of fees for research partners accessing Rejuve Network member data)
4) AI marketplace fees (Proceeds from Rejuve AI service API calls on the SingularityNET marketplace)
5) Proceeds from therapies generated (primarily via Rejuve Biotech)
How does Rejuve.AI (RJV) work?
Longevity App
Our primary product is our mobile app Longevity, which will be available on both Apple Appstore and Google Playstore in all countries, barring any unforeseen legal restrictions. This app has 2 key functions: 1) Providing an easy way to track your personal health data in one place while receiving useful personalized insights and recommendations to improve your health, wellness, and longevity and 2) Allowing you to be a part of cutting-edge longevity research to extend human healthspan and lifespan while earning valuable membership rewards in the process
Our app allows users to:
- Track their personal health data by inputting health data across various metrics including surveys, health inventories, lab test results, wearables data, and eventually genome data
- Calculate their approximate Biological Age
- Receive personalized insights framed around the Hallmarks of Aging, and an additional view framed around specific areas of health
- Earn tokens in exchange for officially contributing their health data to our research database
- Use tokens to redeem valuable products in our in-app Reward Store
The app Beta is live and can be accessed here: https://rejuve-ai.eo.page/signup with an expected live launch in Q1 2023.
Bayes Expert (first AI system)
Our other currently live product is our Premier AI service Bayes Expert. Running in the app Beta now, Bayes Expert is an innovative system that allows models to be constructed by the input of statistics from scientific papers (specifically systematic reviews and meta-analyses which are the most comprehensive type). These models calculate risk levels based on these statistics. These models can be used in any application, but the customized net built for Rejuve is focused on longevity via the 9 + 1 Hallmarks of aging.
This net is made up of over 400 nodes and 150 meta analyses and systematic reviews from reputable medical journals, based on 1500+ gold standard Randomized Controlled Trials on over 12.5 million subjects. As further backing, we also utilized machine learning on NHANES Survey data from 1999-2022 which contains data from over 85,000 data contributors.
This service is running on the SingularityNET platform on the backend, with front end UI interface expected for Q2 2023.
Other Products to Be Developed
Along with these currently running live products, we have several others in the pipeline (noted in the Roadmap section) which consist of our other unique AI systems, along with any resulting therapeutics that result from our work. Here is a description of the AI-related products:
A. Modular Transformer VAE
An unsupervised learning compositional neural network that allows inferences to be made between different parts of a user’s state, for example between different types of data. The unique feature of this system is to be able to “fill in the gaps” in the data profiles, for example if a user does not have blood test results it can make more accurate assessments of where these values would sit based on the relationships between the other data they input plus the blood test data of other users with similar profiles.
The MTVAE will also be used for combining neural nets within the GCN (our final component) helping to make a more accurate digital simulation of the human body across multiple aspects or resolutions. The first application of this service in the Longevity app will be to improve the Biological Age calculation.
This service is expected to be implemented in the app and deployed on the SingularityNET marketplace by Q4 2023.
B. Generative Cooperative Network (GCN)
Our third and most intricate Rejuve native AI service is the GCN. The name is in part derived from the GAN (Generative Adversarial Network), having in common the coevolving agents create more accurate generative models, but instead of exclusively competing with one another, they cooperate with one another to lead to evolutionary learning.
The key feature of this system is the ability to enable contribution of models not only from our own native AI systems, but from other developers, and combine these models to generate a holistic, evolving picture of the human body (generally and individually). The GCN will also be used in SingularityNET’s OpenCog Hyperon in collaboration with Rejuve Biotech to further the flies-to-humans research, along with other exciting applications.
This system is expected to deploy on the marketplace and in the app in 2024.
C. Multiresolutional Simulation of the Human Body
In continuity with the above, the GCN, which compromises all the data and models contributed from the other services and user-contributed AI models, will generate a digital simulation of the human body, which can be used for personalized & medicine applications, synthetic clinical trials, and overall deeper understanding of how the human system works in order to extend health & lifespan. Once matured, this can be demonstrated via attractive UI for clinicians and end users.
What is Rejuve.AI (RJV) marketing strategy?
Our initial users primarily come from the SingularityNET ecosystem, which has already successfully launched the SingularityDAO and NuNet projects, with many more to come. RejuveAI already has over 3000+ followers on Twitter, 1500+ on Telegram, and increasing daily. There is great interest in our project and launch from our supportive community, with a history of closing out TGE’s in minutes to seconds.
We will continue our marketing efforts with video content, podcasts, conferences, press releases, and partner outreach. We already have partnerships with industry-leading brands (outlined in Partners section below) which will help spread knowledge of our app and project to a wider audience. We will also utilize health-tech and blockchain-specific PR agencies to increase our reach adoption.
What are Rejuve.AI (RJV) token utilities?
The Rejuve Network token economy consists of 3 tokens:
- Data (dNFT) - A non-fungible ERC-271 distributed identity token that is associated with every data-contributing member of the Rejuve Network, including data contributors, labs, individual researchers, data modelers, companies, employees, and contractors. These ID NFTs are minted at no cost to members and are used to grant and keep track of data usage permission through a dashboard in the Longevity app. dNFTs cannot be bought or sold, and only one dNFT can be minted per user (linked to KYC). Users have an option to burn this token if they wish to disassociate from the Network/have their data removed from the Data Commons.
- RJV utility token - A fungible ERC-20 token through which transactions between network members are made, and through which members are given rewards for data contributions. A fixed number will be minted upon network formation.
- Product NFT (pNFT) - A token consisting of an ERC-721 NFT sharded (fractionalized) into ERC-20 utility tokens, that are distributed to data owners in proportion to their contribution to a generated product (for example a drug or therapy). pNFTs are minted at a predetermined endpoint (for example at time of patent filing, or suggestion of a lab from a hypothesis generated by Rejuve’sAI). This NFT represents the data contributors' ownership share in the product. Proceeds from the product itself are distributed in the form of RJV tokens to pNFT shard holders in proportion to the amount of shards they hold. One pNFT is minted per product ideation. pNFT shards are distributed to users proportionally based on their contribution to that product, calculated by an AI algorithm. The distribution of these shards is done in batches, wih the first batch distributed to initial data contributors, with other batches distributed after further studies and clinical trials. Once the product reaches a certain stage of maturity where no more data is needed to be contributed, any remaining shards will be burned. Data owners can sell up to 50% of their shards initially, with the other half locked for a period of time, in order to prevent exploitation/assure that they maintain ownership of products made from their data. Rejuve Network will receive a certain portion of all minted pNFTs, and allocate a portion of the tokens earned from its own shard proceeds to a pool to continually fund token rewards that incentivize data contribution.
*Details of this plan are subject to applicable laws and are subject to future revision according to legal advice.